Biology of Demyelinating Diseases 575
Garbern JY (2005) Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the
roles of proteolipid protein 1 in the nervous system. J Neurol Sci 228:201–203
Garbern JY, Cambi F, Tang XM, Sima AA, Vallat JM, Bosch EP, Lewis R, Shy M, Sohi J, Kraft G,
Chen KL, Joshi I, Leonard DG, Johnson W, Raskind W, Dlouhy SR, Pratt V, Hodes ME, Bird
T, Kamholz J (1997) Proteolipid protein is necessary in peripheral as well as central myelin.
Neuron 19:205–218
Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans
EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) Patients
lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent
axonal degeneration in the absence of demyelination and inflammation. Brain 125:
551–561
Gatewood JD, Morgan MD, Eaton M, McNamara IM, Stevens LF, Macbeth AH, Meyer EA, Lomas
LM, Kozub FJ, Lambert KG, Kinsley CH (2005) Motherhood mitigates aging-related decre-
ments in learning and memory and positively affects brain aging in the rat. Brain R es Bull
66:91–98
Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A (2007) Glia: the fulcrum of brain
diseases. Cell Death Differ 14:1324–1335
Gieselmann V, Franken S, Klein D, Mansson JE, Sandhoff R, Lullmann Rauch R, Hartmann D,
Saravanan VP, De Deyn PP, D’Hooge R, Van Der Linden AM, Schaeren-Wiemers N (2003)
Metachromatic leukodystrophy: consequences of sulphatide accumulation. Acta Paediatr Suppl
92:74–79; discussion 45
Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating
Schwann cells with a possible role in axonal ensheathment. Neuron 12:497–508
Givogri MI, Costa RM, Schonmann V, Silva AJ, Campagnoni AT, Bongarzone ER (2002) Central
nervous system myelination in mice with deficient expression of Notch1 receptor. J Neurosci
Res 67:309–320
Goldberg JL, Barres BA (2000) Nogo in nerve regeneration. Nature 403:369–370
Gow A, Sharma R (2003) The unfolded protein response in protein aggregating diseases.
Neuromolecular Med 4:73–94
Gow A, Southwood CM, Lazzarini RA (1998) Disrupted proteolipid protein trafficking results in

oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol
140:925–934
Graham DI, Lantos PA (1997) Greenfield’s Neuropathology, 6th edn. Arnold, London
Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S (2007) White matter
plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27:1812–1823
Hagemann TL, Connor JX, Messing A (2006) Alexander disease-associated glial fibrillary acidic
protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
J Neurosci 26:11162–11173
Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat JM (2001) Pathological findings in the x-
linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta
Neuropathol (Berl) 101:129–139
Haroutunian VP, Davis KL (2007) Introduction to the special section: Myelin and oligodendrocyte
abnormalities in schizophrenia. Int J Neuropsychopharmacol 10:499–502
Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL (2007) Variations in oligodendrocyte-
related gene expression across multiple cortical regions: implications for the pathophysiology
of schizophrenia. Int J Neuropsychopharmacol 10:565–573
Hausler M, Anhuf D, Schuler H, Ramaekers VT, Thron A, Zerres K, Moller-Hartmann W (2005)
White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indi-
cates demyelination or increased myelin turnover rather than dysmyelination. Neuroradiology
47:83–86
Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T,
Yoshida N, Wada Y, Taniguchi N (2002) Paranodal junction formation and spermatogenesis
require sulfoglycolipids. Proc Natl Acad Sci U S A 99:4227–4232
576 D. Pham-Dinh and N. Baumann
Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, Vora AJ, Brophy PJ,
Reynolds R (2006) Disruption of neurofascin localization reveals early changes preceding
demyelination and remyelination in multiple sclerosis. Brain 129:3173–3185
Ilyas AA, Chen ZW, Cook SD (2003) Antibodies to sulfatide in cerebrospinal fluid of patients with
multiple sclerosis. J Neuroimmunol 139:76–80
Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD (2006) Astrocytes

promote myelination in response to electrical impulses. Neuron 49:823–832
Ishibashi T, Ding L, Ikenaka K, Inoue Y, Miyado K, Mekada E, Baba H (2004) Tetraspanin protein
CD9 is a novel paranodal component regulating paranodal junctional formation. J Neurosci
24:96–102
Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H,
Baba H (2002) A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on
myelinated axon but not essential for initial cluster formation. J Neurosci 22:6507–6514
Jagannathan NR, Tandon N, Raghunathan P, Kochupillai N (1998) Reversal of abnormalities
of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton
magnetic resonance spectroscopy (MRS) study. Brain Res Dev Brain Res 109:179–186
Jessen KR, Mirsky R (1991) Schwann cell precursors and their development. Glia 4:185–194
John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002)
Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte
maturation. Nat Med 8:1115–1121
Jung-Testas I, Do Thi A, Koenig H, Desarnaud F, Shazand K, Schumacher M, Baulieu EE (1999)
Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J Steroid Biochem Mol
Biol 69:97–107
Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband
M, Lappe-Siefke C, Yu K, Ornitz DM, Nave KA, Bansal R (2006) Mice with conditional
inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal
myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci
26:12339–12350
Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006)
Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:
138–143
Karadottir R, Attwell D (2007) Neurotransmitter receptors in the life and death of oligodendro-
cytes. Neuroscience 145:1426–1438
Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Kirkham D, Anderson TJ, Nave KA,
Griffiths IR, McLaughlin M (2007) PLP-1 overexpression perturbs myelin protein composition
and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia 55:341–351

Karlsson KA, Samuelsson BE, Steen GO (1974) The lipid composition and Na+-K+-dependent
adenosine-triphosphatase activity of the salt (nasal) gland of eider duck and herring gull. A role
for sulphatides in sodium-ion transport. Eur J Biochem 46:243–258
Karoutzou G, Emrich HM, Dietrich DE (2007) The myelin-pathogenesis puzzle in schizophrenia:
a literature review. Mol Psychiatry 13(3):245–260
Keirstead HS, Levine JM, Blakemore WF (1998) Response of the oligodendrocyte progenitor
cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22:
161–170
Kubicki M, McCarley RW, Shenton ME (2005) Evidence for white matter abnormalities in
schizophrenia. Curr Opin Psychiatry 18:121–134
Kuerten S, Kostova-Bales DA, Frenzel LP, Tigno JT, Tary-Lehmann M, Angelov DN, Lehmann
PV (2007) MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain,
spinal cord and cerebellum. J Neuroimmunol 189:31–40
Kuerten S, Lichtenegger FS, Faas S, Angelov DN, Tary-Lehmann M, Lehmann PV (2006) MBP-
PLP-1 fusion protein-induced EAE in C57BL/6 mice. J Neuroimmunol 177:99–111
Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham-Dinh D, Villoslada P, von Budingen
HC, Genain CP (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic
markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 103:2280–2285
Biology of Demyelinating Diseases 577
Larocque D, Richard S (2005) QUAKING KH domain proteins as regulators of glial cell fate and
myelination. RNA Biol 2:37–40
Lassmann H (2004) Experimental autoimmune encephalomyelitis. In: LazzariniRA(ed) Myelin
Biology and Disorders. Elsevier Academic Press, San Diego, CA, pp 1039–1071
Lazzarini R (2004) Myelin biology and disorders. Elsevier Academic Press, San Diego, CA
Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach
D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk
JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in
leukoencephalopathy with vanishing white matter. Nat Genet 29:383–388
Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS development
and disease. Glia 54:1–10

Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, Sherrington R, Adolfsson
R, Jazin E (2001) A schizophrenia-susceptibility locus at 6q25, in one of the world’s largest
reported pedigrees. Am J Hum Genet 69:96–105
Lopate G, Pestronk A, Evans S, Li L, Clifford D (2005) Anti-sulfatide antibodies in HIV-infected
individuals with sensory neuropathy. Neurology 64:1632–1634
Lubetzki C, Demerens C, Anglade P, Villarroya H, Frankfurter A, Lee VM, Zalc B (1993)
Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci U S A 90:
6820–6824
Lubetzki C, Stankoff B (2000) Role of axonal signals in myelination of the central nervous system.
Pathol Biol (Paris) 48:63–69
Lubetzki C, Williams A, Stankoff B (2005) Promoting repair in multiple sclerosis: problems and
prospects. Curr Opin Neurol 18:237–244
Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: an
ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612
Ludwin SK (1994) Central nervous system remyelination: studies in chronically damaged tissue.
Ann Neurol 36(Suppl):S143–S145
Macklin WB, C ampagnoni CW, Deininger PL, Gardinier MV (1987) Structure and expression of
the mouse myelin proteolipid protein gene. J Neurosci Res 18:383–394
Maier O, van der Heide T, Johnson R, de Vries H, Baron W, Hoekstra D (2006) The function
of neurofascin155 in oligodendrocytes is regulated by metalloprotease-mediated cleavage and
ectodomain shedding. Exp Cell Res 312:500–511
Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL (2006) Sulfatide is essential
for the maintenance of CNS myelin and axon structure. Glia 53:372–381
Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK (2004)
Oligodendrocytes and progenitors become progressively depleted within chronically demyeli-
nated lesions. Am J Pathol 164:1673–1682
Mastronardi FG, Moscarello MA (2005) Molecules affecting myelin stability: a novel hypothesis
regarding the pathogenesis of multiple sclerosis. J Neurosci Res 80:301–308
Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination
and remyelination in the central nervous system. Brain Pathol 11:107–116

Mattei MG, Alliel PM, Dautigny A, Passage E, Pham-Dinh D, Mattei JF, Jolles P (1986) The
gene encoding for the major brain proteolipid (PLP-1) maps on the q-22 band of the human X
chromosome. Hum Genet 72:352–353
Matute C (2006) Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol Med
12:289–292
McInnes LA, Lauriat TL (2006) RNA metabolism and dysmyelination in schizophrenia. Neurosci
Biobehav Rev 30:551–561
Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL (2003) Connexins are critical
for normal myelination in the CNS. J Neurosci 23:5963–5973
Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A
(2006) Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26:
7907–7918
578 D. Pham-Dinh and N. Baumann
Meyer zu Horste G, Prukop T, Nave KA, Sereda MW (2006) Myelin disorders: causes and
perspectives of Charcot-Marie-Tooth neuropathy. J Mol Neurosci 28:77–88
Mi S, Hu B, Hahm K, Luo Y, Kam Hui ESZ, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo
J, Zhang W, So KF, Perpinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W (2007)
Lingo-1 antagnonist promotes spinal cord remyelination and axonal integrity in MOG-induced
experimental auto-immune encephalomyelitis. Nat Med 13:1228–3123
Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque
M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB
(2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:
745–751
Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C,
Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science
304:700–703
Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D (2004)
Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci
61:369–385
Mignot C, Delarasse C, Escaich S, Della Gaspera B, Noe E, Colucci-Guyon E, Babinet C, Pekny

M, Vicart P, Boespflug-Tanguy O, Dautigny A, Rodriguez D, Pham-Dinh D (2007) Dynamics
of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander
disease. Exp Cell Res 313:2766–2779
Mignot C, Desguerre I, Burglen L, Hertz-Pannier L, Renaldo F, Gadisseux JF, Gallet S, Pham-Dinh
D, Boespflug-Tanguy O, Rodriguez D (2009) Tumor-like enlargement of the optic chiasm in
an infant with Alexander disease. Brain Dev 31:244–247
Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-Acetylaspartate in the
CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89–131
Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P
(1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC
transporters. Nature 361:726–730
Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC,
Reynolds R, Baron-Van Evercooren A (2007) Activation of the subventricular zone in multiple
sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104:4694–4699
Nie DY, Ma QH, Law JW, Chia CP, Dhingra NK, Shimoda Y, Yang WL, Gong N, Chen QW, Xu G,
Hu QD, Chow PK, Ng YK, Ling EA, Watanabe K, Xu TL, Habib AA, Schachner M, Xiao ZC
(2006) Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule
OMgp. Neuron Glia Biol 2:151–164
Nishiyama A, Chang A, Trapp BD (1999) NG2+ glial cells: a novel glial cell population in the
adult brain. J Neuropathol Exp Neurol 58:1113–1124
Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes
the human brain. Trends Neurosci 29:547–553
Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore
SA, Chen ZL, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri ML (2005) Both laminin
and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes
of Ranvier. J Neurosci 25:9418–9427
Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, Yang Y, Susuki K, Peles E, Stankewich MC,
Rasband MN (2006) Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J
Neurosci 26:5230–5239
Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS (2007) Loss-of-function

GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci
34:629–641
Owens GC, Bunge RP (1989) Evidence for an early role for myelin-associated glycoprotein in the
process of myelination. Glia 2:119–128
Park SK, Miller R, Krane I, Vartanian T (2001a) The erbB2 gene is required for the development
of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 154:1245–1258
Biology of Demyelinating Diseases 579
Park SK, Solomon D, Vartanian T (2001b) Growth factor control of CNS myelination. Dev
Neurosci 23:327–337
Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp
A, Pellissier JF, Fontes M (2004) Ascorbic acid treatment corrects the phenotype of a mouse
model of Charcot-Marie-Tooth disease. Nat Med 10:396–401
Peles E, Salzer JL (2000) Molecular domains of myelinated axons. Curr Opin Neurobiol 10:
558–565
Pham-Dinh D, Dautigny A, Linington C (2004) The myelin/oligodendrocyte glycoprotein
(MOG): structure and physiopathological functions. In: LazzariniRA(ed) Myelin Biology and
Disorders. Elsevier Academic Press, San Diego, CA, pp 469–498
Pham-Dinh D, Mattei MG, Nussbaum JL, Roussel G, Pontarotti P, Roeckel N, Mather IH, Arzt K,
Lindahl KF, Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset
of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc
Natl Acad Sci U S A 90:7990–7994
Picard-Riera N, Decker L, Delarasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D,
Barron van Evercooren A (2002) Experimental autoimmune encephalomyelitis mobilizes neu-
ral progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc
Natl Acad Sci U S A 99:13211–13216
Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant
S, Moore SB, Keegan BM, Lucchinetti CF (2007) Myelin oligodendrocyte glycoprotein anti-
bodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic
correlations. Mult Scler 13:7–16
Powers JM (2005) Demyelination in peroxisomal diseases. J Neurol Sci 228:206–207

Pujol JC, Soriano-Mas H, Ortiz N, Sebastian-Galles JM, Losilla JM, Deus J (2006) Myelination of
language-related areas in the developing brain. Neurology 66:339–343
Quarles RH (2007) Myelin-associated glycoprotein (MAG): past, present and beyond. J
Neurochem 100:1431–1448
Quinlan RA, Brenner M, Goldman JE, Messing A (2007) GFAP and its role in Alexander disease.
Exp Cell Res 313:2077–2087
Raine CS, Traugott U, Farooq M, Bornstein MB, Norton WT (1981) Augmentation of immune-
mediated demyelination by lipid haptens. Lab Invest 45:174–182
Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA, Bansal R (2005) CNP is
required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50:
86–90
Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre
M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner
U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J (2006) Late-
onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67:
859–863
Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC (2007) Myelin staining of
deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and
unipolar major depression. Psychiatry Res 151:179–188
Roach A, Boylan K, Horvath S, Prusiner SB, Hood LE (1983) Characterization of cloned cDNA
representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice.
Cell 34:799–806
Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N’Guyen S, Goizet C, Gelot A, Surtees
R, Pedespan JM, Hernandorena X, Troncoso M, Uziel G, Messing A, Ponsot G, Pham-Dinh
D, Dautigny A, Boespflug-Tanguy O (2001) Infantile Alexander disease: spectrum of GFAP
mutations and genotype-phenotype correlation. Am J Hum Genet 69:1134–1140
Rodriguez D, Gelot A, Della Gaspera B, Robain O, Ponsot G, Sarlieve LL, Ghandour S, Pompidou
A, Dautigny A, Aubourg P, Pham-Dinh D (1999) Increased density of oligodendrocytes in
childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological
and biochemical study of two cases. Acta Neuropathol (Berl) 97:469–480

580 D. Pham-Dinh and N. Baumann
Rogister B, Ben-Hur T, Dubois-Dalcq M (1999) From neural stem cells to myelinating oligoden-
drocytes. Mol Cell Neurosci 14:287–300
Rosenbluth J, Nave KA, Mierzwa A, Schiff R (2006) Subtle myelin defects in PLP-1-null mice.
Glia 54:172–182
Rosenbluth J, Schiff R, Liang WL, Dou W (2003) Antibody-mediated CNS demyelination II. Focal
spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma. J
Neurocytol 32:265–276
Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C,
Moore H, O’Donnell P, Brunner D, Corfas G (2007) Loss of erbB signaling in oligodendrocytes
alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.
Proc Natl Acad Sci U S A 104:8131–8136
Saravanan K, Schaeren-Wiemers N, Klein D, Sandhoff R, Schwarz A, Yaghootfam A,
Gieselmann V, Franken S (2004) Specific downregulation and mistargeting of the
lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol Dis 16:
396–406
Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter
U (2004) The raft-associated protein MAL is required for maintenance of proper axon–glia
interactions in the central nervous system. J Cell Biol 166:731–742
Scherer SS, Deschenes SM, Xu YT, Grinspan JB, Fischbeck KH, Paul DL (1995) Connexin32 is a
myelin-related protein in the PNS and CNS. J Neurosci 15:8281–8294
Schiffmann R, Elroy-Stein O (2006) Childhood ataxia with CNS hypomyelination/vanishing white
matter disease – a common leukodystrophy caused by abnormal control of protein synthesis.
Mol Genet Metab 88:7–15
Schumacher M, Guennoun R, Stein DG, De Nicola AF (2007) Progesterone: therapeutic opportu-
nities for neuroprotection and myelin repair. Pharmacol Ther 116:77–106
Seldon HL (2007) Extended neocortical maturation time encompasses speciation, fatty acid
and lateralization theories of the evolution of schizophrenia and creativity. Med Hypotheses
69(5):1085–1089
Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA (2003) Therapeutic administration

of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med
9:1533–1537
Shy ME (2004) Charcot-Marie-Tooth disease: an update. Curr Opin Neurol 17:579–585
Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien
J, Garbern JY, Kamholz J (2004) Phenotypic clustering in MPZ mutations. Brain 127:
371–384
Simons M, Trajkovic K (2006) Neuron-glia communication in the control of oligodendrocyte
function and myelin biogenesis. J Cell Sci 119:4381–4389
Smith EJ, Blakemore WF, McDonald WI (1979) Central remyelination restores secure conduction.
Nature 280:395–396
Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates
disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585–596
Sow A, Lamant M, Bonny JM, Larvaron P, Piaud O, Lecureuil C, Fontaine I, Saleh MC, Garcia
Otin AL, Renou JP, Baron B, Zakin M, Guillou F (2006) Oligodendrocyte differentiation is
increased in transferrin transgenic mice. J Neurosci Res 83:403–414
Spencer T, Domeniconi M, Cao Z, Filbin MT (2003) New roles for old proteins in adult CNS
axonal regeneration. Curr Opin Neurobiol 13:133–139
Spiegel I, Peles E (2006) A new player in CNS myelination. Neuron 49:777–778
Stangel M, Hartung HP (2002) Remyelinating strategies for the treatment of multiple sclerosis.
Prog Neurobiol 68:361–376
Staugaitis SM, Smith PR, Colman DR (1990) Expression of myelin basic protein isoforms in
nonglial cells. J Cell Biol 110:1719–1727
Steinman L (2001) Blockade of gamma interferon might be beneficial in MS. Mult Scler 7:
275–276
Biology of Demyelinating Diseases 581
Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic
encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12–21
Stevens B (2006) Cross-talk between growth factor and purinergic signalling regulates
Schwann cell proliferation. Novartis Found Symp 276:162–175; discussion 175–80, 233–237,
275–81

Stevens B, Fields RD (2000) Response of Schwann cells to action potentials in development.
Science 287:2267–2271
Stevens B, Ishibashi T, Chen JF, Fields RD (2004) Adenosine: an activity-dependent axonal sig-
nal regulating MAP kinase and proliferation in developing Schwann cells. Neuron Glia Biol
1:23–34
Stevens B, Porta S, Haak LL, Gallo V, Fields RD (2002) Adenosine: a neuron-glial transmitter
promoting myelination in the CNS in response to action potentials. Neuron 36:855–868
Stewart DG, Davis KL (2004) Possible contributions of myelin and oligodendrocyte dysfunction
to schizophrenia. Int Rev Neurobiol 59:381–424
Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ (2004) Notch1 and
Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor
during remyelination. Brain 127:1928–1941
Suzuki K (2003) Globoid cell leukodystrophy (Krabbe’s disease): update. J Child Neurol 18:
595–603
Suzuki K, Kikkawa Y (1969) Status spongiosus of CNS and hepatic changes induced by cuprizone
(biscyclohexanone oxalyldihydrazone). Am J Pathol 54:307–325
Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T, Itohara S, Kato H, Ikenaka
K (2007) Murine model of Alexander disease: analysis of GFAP aggregate formation and its
pathological significance. Glia 55:617–631
Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA,
Shrager P, Chao MV, Falls DL, Role L, Salzer JL (2005) Neuregulin-1 type III determines the
ensheathment fate of axons. Neuron 47:681–694
Teijido O, Casaroli-Marano R, Kharkovets T, Aguado F, Zorzano A, Palacin M, Soriano E,
Martinez A, Estevez R (2007) Expression patterns of MLC1 protein in the central and
peripheral nervous systems. Neurobiol Dis 26:532–545
Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G,
Trapp BD (2002) The tetraspanin protein, CD9, is expressed by progenitor cells commit-
ted to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia 40:
350–359
Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang

J, Nedergaard M (2005) An astrocytic basis of epilepsy. Nat Med 11:973–981
Tian DS, Dong Q, Pan DJ, He Y, Yu ZY, Xie MJ, Wang W (2007) Attenuation of astrogliosis by
suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal
cord injury model. Brain Res 1154:206–214
Tian R, Gregor M, Wiche G, Goldman JE (2006) Plectin regulates the organization of glial fibrillary
acidic protein in Alexander disease. Am J Pathol 168:888–897
Tiwari-Woodruff S, Beltran-Parrazal L, Charles A, Keck T, Vu T, Bronstein J (2006) K+ chan-
nel KV3.1 associates with OSP/claudin-11 and regulates oligodendrocyte development. Am J
Physiol Cell Physiol 291:C687–C698
Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, Nicoletti F, Pozzilli C (2005)
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg
Psychiatry 76:272–275
Tominaga K, Matsuda J, Kido M, Naito E, Yokota I, Toida K, Ishimura K, Suzuki K, Kuroda
Y (2004) Genetic background markedly influences vulnerability of the hippocampal neuronal
organization in the “twitcher” mouse model of globoid cell leukodystrophy. J Neurosci Res
77:507–516
Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, Havaki S, Iwakura Y, Fukamauchi F,
Watanabe K, Soliven B, Girault JA, Karagogeos D (2003) Association of TAG-1 with Caspr2
582 D. Pham-Dinh and N. Baumann
is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell
Biol 162:1161–1172
Trapp BD, Pfeiffer SE, Anitei M, Kidd G (2004) Cell biology of myelin assembly. In: Lazzarini RA
et al (eds) Myelin biology and disorders. Elsevier Academic Press, New York, NY, pp 29–55
Turpin JC, Jouas M, Sereni C, Pluot M, Baumann N (1985) Révélation à l’âge adulte d’un cas
d’adrénoleucodystrophie familiale. Rev Neurol 141:289–295
Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-
Didinger G, Aksu F, Topaloglu H, Nurnberg P, Hubner C, Weschke B, Gartner J (2004)
Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-
Merzbacher-like disease. Am J Hum Genet 75:251–260
Vesce S, Rossi D, Brambilla L, Volterra A (2007) Glutamate release from astrocytes in physiologi-

cal conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev
Neurobiol 82:57–71
Voas MG, Lyons DA, Naylor SG, Arana N, Rasband MN, Talbot WS (2007) alphaII-spectrin
is essential for assembly of the nodes of Ranvier in myelinated axons. Curr Biol 17:
562–568
von Budingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP (2004) Frontline:
Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences dis-
ease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol
34:2072–2083
von Budingen HC, Menge T, Hauser SL, Genain CP (2006) Restrictive and diversifying elements
of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental
allergic encephalomyelitis. Immunogenetics 58:122–128
Waxman SG, Bangalore L (2003) Electrophysiological consequences of myelination. In: Lazzarini,
RA et al (eds) Myelin Biology and Disorders. Academic Press, New York, NY, pp 117–142
Weimbs T, Stoffel W (1992) Proteolipid protein (PLP-1) of CNS myelin: positions of free,
disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the
membrane topology of PLP-1. Biochemistry 31:12289–12296
Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, Petermann F, Thomas JL, Zalc B,
Lubetzki C (2007b) Semaphorin A and 3F, key players in myelin repair in multiple sclerosis?
Brain 130:2554–2565
Williams A, Piaton G„ Lubetzki C (2007a) Astrocytes-friends or foes in multiple sclerosis? Glia
55:1300–1312
Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain
125:2591–2625
Wilson HC, Scolding NJ, Raine CS (2006) Co-expression of PDGF alpha receptor and NG2 by
oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol
176:162–173
Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent
population of oligodendrocyte precursor cells. J Neurosci 18:601–609
Woodruff RH, Franklin RJ (1999) Demyelination and remyelination of the caudal cerebellar

peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and
complement/anti-galactocerebroside: a comparative study. Glia 5:216–228
Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR (2005) Myelinogenesis and axonal recognition by
oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25:1354–1365
Yakovlev PI, Lecours LA (1966) The myelinogenic cycles of regional maturation of the brain.
BlacKwell, Oxford
Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa
K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and
Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci
U S A 101:11404–11409
Zalc B, Helwig JJ, Ghandour MS, Sarlieve L (1978) Sulfatide in the kidney: how is this lipid
involved in sodium chloride transport? FEBS Lett 92:92–96
Biology of Demyelinating Diseases 583
Zeger M, Popken G, Zhang J, Xuan S, Lu QR, Schwab MH, Nave KA, Rowitch D, D’Ercole AJ,
Ye P (2007) Insulin-like growth factor type 1 receptor signaling in the cells of oligodendro-
cyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia
55:400–411
Zhao C, Fancy SP, Magy L, Urwin JE, Franklin RJ (2005) Stem cells, progenitors and myelin
repair. J Anat 207:251–258